• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Simulations Plus Inc (NQ: SLP )

    31.83 -0.10 (-0.31%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Simulations Plus Inc

    < Previous 1 2 3 4 5 6 7 8 Next >
    Simulations Plus to Present at Baird 2022 Global Healthcare Conference
    From Simulations Plus
    Via Business Wire
    Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease
    From Simulations Plus, Inc.
    Via Business Wire
    Goldman Sachs Boosts Price Target On JinkoSolar Following Q2 Earnings, Also Check Out Other Major PT Changes Here
    Oppenheimer raised the price target on S&P Global Inc. (NYSE: SPGI) from $404 to $419. Oppenheimer analyst Owen Lau maintained an Outperform rating on the stock. S&P Global shares fell 1% to $360.46 in... 
    Via Benzinga
    Can Simulations Plus Stock Maintain Its Impressive Growth?
    Simulations Plus, Inc. held up well in the company’s recently released financial results. 
    Via Talk Markets
    Veeva Systems Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
    Veeva Systems stock reached a key technical milestone, with its Relative Strength Rating, rising to 81 on Tuesday, up from 66 the day before. 
    Via Investor's Business Daily
    Simulations Plus Enters New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa)
    From Simulations Plus, Inc.
    Via Business Wire
    Evolent Health Is In Buy Zone Ahead Of Earnings Announcement
    Medical cost management firm Evolent Health reports late Tuesday. 
    Via Investor's Business Daily
    Simulations Plus Presented New Scientific Developments at PAGE 2022
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer
    From Simulations Plus
    Via Business Wire
    Simulations Plus Realizes Early Success with its Concierge Program
    From Simulations Plus, Inc
    Via Business Wire
    Simulations Plus Reports Third Quarter Fiscal 2022 Financial Results
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Stock Scores Composite Rating Move Up To 96
    The IBD SmartSelect Composite Rating for Simulations Plus stock rose from 94 to 96 Wednesday. The medical software stock has 94 RS Rating. 
    Via Investor's Business Daily
    Earnings Scheduled For July 6, 2022
    Companies Reporting After The Bell • Saratoga Investment (NYSE:SAR) is expected to report quarterly earnings at $0.53 per share on revenue of $19.21 million. 
    Via Benzinga
    Kornit Digital, Simulations Plus And 3 Stocks To Watch Heading Into Wednesday
    With the US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
    Via Benzinga
    Preview: Simulations Plus's Earnings
    Simulations Plus (NASDAQ:SLP) is set to give its latest quarterly earnings report on Wednesday, 2022-07-06. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop
    From Simulations Plus, Inc.
    Via Business Wire
    Jim Cramer Recommends This Mining Company And 5 Other Stocks
    On CNBC’s "Mad Money Lightning Round," Jim Cramer said AT&T Inc (NYSE: T) is a "distinct hold. If it were $18, it’s a buy. If it was $23, it’s a sell." 
    Via Benzinga
    Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 Treatment
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call
    From Simulations Plus, Inc.
    Via Business Wire
    DILIsym Software Publication Outlines Impact on the CGRP Field for Migraine
    From Simulations Plus, Inc.
    Via Business Wire
    Privia Health Stock Among The Few That've Risen This Month
    Privia Health is trying to complete a cup without handle with a 29.07 entry. See if it clears the breakout price in above average volume. 
    Via Investor's Business Daily
    Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)
    From Simulations Plus, Inc.
    Via Business Wire
    U.S. FDA Renews Annual DILIsym Software Licenses for 2022
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Successfully Delivers FDA-Funded Project
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus to Present at the Berenberg Discover AI Seminar
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus: Q2 Earnings Insights
      Simulations Plus (NASDAQ:SLP) reported its Q2 earnings results on Wednesday, April 6, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results
    From Simulations Plus, Inc.
    Via Business Wire
    Earnings Preview For Simulations Plus
    Simulations Plus (NASDAQ:SLP) is set to give its latest quarterly earnings report on Wednesday, 2022-04-06. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
    From Simulations Plus, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.